Hassani Valiollah, Amniati Saied, Kashaninasab Fatemeh, Niakan Mohammad, Moradi Moghadam Omid, Jafarian Ali Akbar, Farahmand Rad Reza, Sehat-Kashani Saloome, Habibi Azadeh
Pain Research Center, Iran University of Medical Sciences, Tehran, Iran.
Mental Health Research Center, Tehran Institute of Psychiatry, Iran University of Medical Sciences, Tehran, Iran.
Anesth Pain Med. 2020 Dec 8;10(6):e107513. doi: 10.5812/aapm.107513. eCollection 2020 Dec.
Electroconvulsive therapy (ECT) was first experienced in 1938 and had been conducting without anesthesia for 30 years. In this study, the most common indication for ECT was mood disorder (major depressive disorder and bipolar I disorder). We introduce a patient with a history of COVID-19 and suicide who required emergency ECT. Electroconvulsive therapy can be life-saving in patients with suicide history or catatonic schizophrenia. Health workers are at the front line of the COVID-19 outbreak control and must follow health instructions. Aerosol-producing procedures such as suction in anesthesia for ECT may facilitate the transmission of infectious diseases such as COVID-19. When performing aerosol-producing procedures during the pandemic of novel coronavirus, every patient should be considered suspicious.
电休克疗法（ECT）于1938年首次应用，在无麻醉的情况下进行了30年。在本研究中，ECT最常见的适应证是情绪障碍（重度抑郁症和双相I型障碍）。我们介绍一位有新冠病毒病（COVID-19）病史且有自杀倾向、需要紧急ECT治疗的患者。电休克疗法对有自杀史或紧张型精神分裂症患者可能是救命的。卫生工作者处于COVID-19疫情防控的第一线，必须遵循卫生指示。ECT麻醉过程中的吸引等产生气溶胶的操作可能会促进COVID-19等传染病的传播。在新型冠状病毒大流行期间进行产生气溶胶的操作时，应将每位患者视为可疑病例。
